What Does MIT Mean in Kratom Products?
MIT is shorthand for mitragynine in the Kratom Paradise catalog. It appears on product names, selector values, and submitted-sample documents. The abbreviation helps identify a product family, but it does not turn every number beside it into the same kind of measurement.
The most reliable way to read an MIT listing is to understand both the pharmacology and the fields: mitragynine is psychoactive, while product format, submitted product-line name, labeled milligram option, laboratory result, net weight, tablet count, flavor, and sample identifier describe different parts of the product record.
What people mean when they ask what MIT does
MIT means mitragynine, the most abundant psychoactive alkaloid usually measured in kratom leaf. Receptor studies show mu-opioid activity, and controlled human research shows measurable mitragynine and 7-OH concentrations after oral kratom consumption.
Mitragynine is not effect-equivalent to concentrated 7-OH, and an MIT label cannot promise one subjective result. Concentration, frequency, tolerance, metabolism, and other substances change the experience, while regular use can involve unwanted effects and dependence.
That is why the number beside MIT needs a basis. A person is not comparing abstract typography; they are comparing potentially meaningful alkaloid exposure. Clear milligram, percentage, count, weight, sample, and report fields help prevent category errors even though they cannot predict an individual's experience.
MIT is not a kratom strain name
Traditional catalog names such as Green Maeng Da, Red Bali, White Borneo, or Gold Bali belong to the botanical powder and leaf-filled capsule lanes. MIT identifies mitragynine-related labeling in a different catalog lane. A product can therefore be MIT-labeled without belonging to a red, green, white, or geographic strain family.
Six fields that should not be collapsed
| Field | Example in the current catalog | Read it as |
|---|---|---|
| Product-line label | MIT 60% or MIT 90% mitragynine | The named extract line or submitted sample label |
| Reported laboratory result | 80.43% or 86.87% mitragynine on the referenced reports | The result reported for that submitted sample |
| Labeled milligram option | 100mg or 200mg MIT | A tablet-listing selector; no unstated per-unit basis should be inferred |
| Net weight | 0.5g through 1kg | The quantity of extract powder in the selected package |
| Tablet count | 5 through 5,000 tablets | The number of units in the selected package |
| Sample identifier | 141215 / SD260616-036 or 141690 / SD260624-014 | The submitted sample described by the linked report |
Submitted label and measured result are separate
The current MIT 60% listing references a report whose submitted sample is labeled MIT 60%. The report's analytical table separately states 80.43% mitragynine, or 804.29 mg/g, for sample SD260616-036. The current MIT 90% mitragynine listing references report 141690, while its analytical table separately states 86.87% mitragynine, or 868.73 mg/g, for sample SD260624-014.
Those examples show why the full record matters. A product-line name should not be rewritten as though it were the laboratory's measured result. Likewise, a report for one submitted sample should not be expanded into an assurance about every flavor, size, packaged unit, or future lot.
What the CH suffix means on report 141690
CH appears in the submitted sample label on report 141690. The report does not define the letters. Kratom Paradise therefore preserves MIT-CH as the laboratory's sample label without inventing an expansion or chemical meaning for the suffix.
No conversion or equivalency is implied
A labeled 100mg or 200mg MIT option is not presented as equivalent to an MIT 60% or MIT 90% mitragynine extract line. Net weight does not equal tablet count. A sample result does not establish a serving. Flavor does not create a new concentration claim. These fields can be recorded together, but they should not be mathematically converted without verified product information that expressly supports the comparison.
MIT and 7-hydroxymitragynine are different terms
Mitragynine and 7-hydroxymitragynine are distinct alkaloid terms. The store's 7-OH vs Kratom vs MIT page explains the category language in more detail. The current extract reports state that 7-hydroxymitragynine was ND at the laboratory's stated reporting threshold for the submitted samples they describe. That result is not a global claim about every tablet, flavor, package, or future lot.
Federal context must also remain precise. FDA states that there are no FDA-approved kratom drug products and that kratom is not lawfully marketed as a dietary supplement or conventional-food additive. HHS and FDA's July 2026 materials distinguish the enhanced 7-OH scheduling action from natural leaf kratom, but that distinction is not federal approval of Kratom Paradise tablets or extracts. See FDA and Kratom and the July 2026 HHS/FDA announcement.
Where each follow-up question belongs
- For format selection: MIT Products Guide.
- For current extract report links: MIT Product Documents & COA Center.
- For laboratory abbreviations and units: How to Read a Kratom Lab Report or COA.
- For batch, lot, and sample matching: Batch, Lot & Sample ID Guide.
- For current product options: MIT Products.
MIT terminology FAQ
Is MIT a kratom strain?
No. It is used here as shorthand for mitragynine in a distinct product-labeling lane.
Does a 100mg label equal a 60% extract label?
No equivalency is stated. The milligram field and product-line percentage are different label fields.
What does CH mean in MIT-CH?
CH appears in the submitted sample label on report 141690. The report does not define it, so this page preserves the label without inventing an expansion.
Is MIT the same term as 7-OH?
No. Mitragynine and 7-hydroxymitragynine are distinct alkaloid terms. Product-specific claims require product-specific evidence.
Label and catalog education only; no medical or legal advice, serving guidance, or product approval is provided.